441 results on '"Hung, Shuen‐Iu"'
Search Results
2. Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions
3. Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer
4. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
5. Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations
6. Advances in the Pathomechanisms of Delayed Drug Hypersensitivity
7. Zinc supplementation is associated with improvement in hand-foot skin reaction in patients on vascular endothelial growth factor receptor-tyrosine kinase inhibitors: A cohort study
8. Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis
9. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions
10. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte–Mediated Bullous Skin Disorders
11. Immunology of Cutaneous Adverse Drug Reactions
12. SJS/TEN 2019: From science to translation
13. Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
14. T‐cell receptor diversity and allergen sensitivity in childhood asthma and atopic dermatitis.
15. Updates in SJS/TEN: collaboration, innovation, and community
16. WITHDRAWN: Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
17. The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions
18. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
19. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
20. Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
21. Randomized, controlled trial of TNF-[alpha] antagonist in CTL-mediated severe cutaneous adverse reactions
22. Immunology of Cutaneous Adverse Drug Reactions
23. Identification of drug-specific public TCR driving severe cutaneous adverse reactions
24. Immune Characteristics and HLA Associations of SARS-Cov-2 Vaccines-induced Delayed-Type Cutaneous Adverse Reactions
25. Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
26. Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response
27. Allopurinol
28. Carbamazepine and Its Structurally-Related Antiepileptics
29. Corrigendum to “Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury”
30. Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma
31. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions
32. Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis
33. Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics
34. Clinicopathologic Analysis of Coxsackievirus A6 New Variant Induced Widespread Mucocutaneous Bullous Reactions Mimicking Severe Cutaneous Adverse Reactions
35. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis
36. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
37. Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies
38. Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
39. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells
40. Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) tissue damage
41. Allopurinol dose relative to renal function and risk of hypersensitivity reactions
42. Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
43. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
44. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
45. Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
46. Corrigendum to ‘SJS/TEN 2019: From science to translation’ [J. Dermatol. Sci. 98/1 (2020) 2–12]
47. Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan
48. Metabolomics reveals microbial‐derived metabolites associated with immunoglobulin E responses in filaggrin ‐related atopic dermatitis
49. The Association of ATG16L1 Variations with Clinical Phenotypes of Adult-Onset Still’s Disease
50. A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.